QPS

QPS will exhibit at the 4th Annual Neuroscience R&D Technologies Conference, October 4-5 in Munich, Germany.

QPS will exhibit at the 4th Annual Neuroscience R&D Technologies Conference, October 4-5 in Munich, Germany. Please stop by our Booth #5 to learn more about QPS’ contract research services. Find out more at qpsneuro.com or email [email protected] #NeuroRnD #QPSLLC #CRO

QPS will exhibit at the 4th Annual Neuroscience R&D Technologies Conference, October 4-5 in Munich, Germany. Read More »

QPS is exhibiting at the 3rd Annual Gene Therapy for Rare Disorders Conference

QPS is exhibiting at the 3rd Annual Gene Therapy for Rare Disorders Conference, between March 26-28 in Boston, MA. If you are attending the meeting, please visit us to learn more about QPS’ range of services. We have supported gene therapy since 2002: ASOs, siRNAs, miRNA through mRNAs and viral vectors utilizing LC-HRMS, hybridization-LC, and

QPS is exhibiting at the 3rd Annual Gene Therapy for Rare Disorders Conference Read More »

lantern

Spreading Early Clinical Knowledge

Shoulder to shoulder with our clients, we at QPS like to share the results of our early clinical research efforts, published in the scientific literature. Learn more by reading: A Phase 1, Single-center, Double-blind, Placebo-controlled Study in Healthy Subjects to Assess the Safety, Tolerability, Clinical Effects, and Pharmacokinetics-Pharmacodynamics of Intravenous Cyclopropyl-methoxycarbonylmetomidate (ABP-700) after a Single

Spreading Early Clinical Knowledge Read More »

Translational Medicine Now Bigger and Better at QPS

Goodbye boutique CRO, hello large study BIG PLAYER! For a long time, you’ve known us as THE high quality outfit that can stabilize difficult assays in the initial stages of clinical investigation. But we’ve been investing in additional technical personnel and laboratory capacity for translational medicine at our Flagship Delaware Technology Park facility. And now

Translational Medicine Now Bigger and Better at QPS Read More »

QPS’ Paul Lehman to Speak at Transdermal & Intradermal Drug Delivery Conference

The 2017 Transdermal & Intradermal Drug Delivery Systems conference covering Advanced Design, Development & Delivery of Skin-Mediated Therapies and Vaccines is coming up on September 28-29 at the venerable Racquet Club of Philadelphia. Don’t miss Paul Lehman, VP and Head of Dermal & Transdermal Research Services at QPS, presenting “Evolution of the In Vitro Permeation

QPS’ Paul Lehman to Speak at Transdermal & Intradermal Drug Delivery Conference Read More »

QPS Study Shows Estetrol Promising for Prostate Cancer Treatment

An investigation into the efficacy and safety of Estetrol (E4) for potential use in the treatment of advanced prostate cancer demonstrated decreased testosterone levels along with acceptable safety parameters. These results suggest that E4 may be suitable for standalone or combination treatment with androgen deprivation therapy (ADT). QPS Netherlands performed the Phase II randomized, double-blind,

QPS Study Shows Estetrol Promising for Prostate Cancer Treatment Read More »

Scroll to Top